The Global Fill-Finish Manufacturing Market is expanding due to rising demand for injectable drugs, driven by biologics and ...

ST. LOUIS--(BUSINESS WIRE)--Kindeva Drug Delivery (Kindeva), a leading global CDMO, today announced two key milestones for its state-of-the-art Bridgeton, MO, facility. The site has successfully ...

RANKWEIL, Austria--(BUSINESS WIRE)--Rentschler Fill Solutions GmbH, a CMO and expert for aseptic fill and finish services, today announced a collaboration with Ultragenyx Pharmaceutical, Inc. for the ...

(MENAFN- GlobeNewsWire - Nasdaq) The aseptic fill finish market size is calculated at USD 6.71 billion in 2025 and is expected to reach around USD 17.17 billion by 2034, growing at a CAGR of 11.04% ...

AST, a U.S leader in the drug product manufacturing industry and Marchesini Group, leader in pharmaceutical packaging ...

GRAND RAPIDS, Mich., June 30, 2020 /PRNewswire/ -- Grand River Aseptic Manufacturing ("GRAM"), an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its ...

Integrated isolators, sterilization technologies, and filling solutions deliver proven sterility, reliability, and efficiency ...

New drug development is focused largely on biopharmaceuticals rather than chemicals, which means the resultant drugs tend to be injectable liquids instead of solids. Furthermore, the new drugs are ...

The growing concern to maintain pharmacological efficacy and product quality, to ensure patient's safety, has led to a greater focus on the need for aseptic fill / finish; drug developers prefer to ...

Stirling, UK - 30th September 2025: Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organisation (CMO) specialising in the sterile manufacture of injectable drug ...

Vaccines to prevent or ease the symptoms of COVID-19 were eagerly awaited in 2020 during the heart of the public health crisis. A contract development and manufacturing organization in Grand Rapids, ...